Showing results (2261-2270 of 31,410) with videos related to
Sort By:
Pageof 3,141
Journal of Medicinal Chemistry|September 27, 1996
Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonistsG Costantino, R PellicciariJournal of Medicinal Chemistry|September 27, 1996
The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptorsL W Boteju, G V Nikiforovich, C Haskell-Luevano, et al.Journal of Medicinal Chemistry|August 30, 1996
Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific "peripheral-type" benzodiazepine receptor ligandsG Campiani, V Nacci, I Fiorini, et al.Journal of Medicinal Chemistry|August 30, 1996
Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidinesT E Renau, C Kennedy, R G Ptak, et al.Journal of Medicinal Chemistry|August 30, 1996
10-substituted 11-oxygenated (R)-aporphines: synthesis, pharmacology, and modeling of 5-HT1A receptor interactionsM H Hedberg, J M Jansen, G Nordvall, et al.Journal of Medicinal Chemistry|August 30, 1996
11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactionsM H Hedberg, T Linnanen, J M Jansen, et al.Journal of Medicinal Chemistry|August 30, 1996
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureasP Y Lam, Y Ru, P K Jadhav, et al.Journal of Medicinal Chemistry|August 30, 1996
Nonlinear quantitative structure-activity relationship for the inhibition of dihydrofolate reductase by pyrimidinesJ D HirstJournal of Medicinal Chemistry|August 30, 1996
Synthesis and evaluation of aryl-substituted N-(arylethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamines and corresponding arylacetamides for sigma receptor affinityY Zhang, W Williams, W D Bowen, et al.Journal of Medicinal Chemistry|August 30, 1996
ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzymeA D Gribble, R E Dolle, A Shaw, et al.Pageof 3,141